76%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
76%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
76%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
76%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
GE HealthCare Technologies
Closed
SectorHealthcare
71.61 0.18
Overview
Share price change
24h
Min
70.85
Max
72.37
Income | -150M 588M |
|---|---|
Sales | -542M 4.8B |
P/E Sector Avg | 14.737 51.198 |
EPS | 1.01 |
Dividend yield | 0.2 |
Profit margin | 12.309 |
Employees | 53,000 |
EBITDA | -456M 629M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +18.74% upside |
Dividend yield Sector Avg | 0.20% 2.40% |
|---|---|
Next Earnings | 30 lip 2025 |
Next Dividend date | 14 sie 2025 |
Next Ex Dividend date | 18 lip 2025 |
Market Cap | -9.7B 32B |
|---|---|
Previous open | 71.43 |
Previous close | 71.61 |
News Sentiment
By Acuity
57%
43%
328 / 380 Ranking in Healthcare
GE HealthCare Technologies Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
GE HealthCare Technologies Forecast
Price Target
By TipRanks
18.74% upside
12 Months Forecast
Average 84.46 USD 18.74%
High 95 USD
Low 73 USD
Based on 13 Wall Street analysts offering 12 month price targets forGE HealthCare Technologies - Dist in the last 3 months.
Sentiment
By Acuity
328 / 380 Ranking in Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About GE HealthCare Technologies
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
